QQ客服 官方微博 反馈留言

	In Vitro and In Vivo Primary Metabolic Characterization of F18, a Novel Histone Deacetylase-6 (HDAC6) Inhibitor, Using UHPLC-QqQ-MS/MS and Q-TOF-MS Methods
	Li, Xiaobin[1,2]; Tang, Minghai[1]; Wang, Hairong[1,2]; Ma, Liang[3]; Ye, Haoyu[1]; Wang, Chunyu[1]; Yang, Qiunan[1,2]; Wan, Li[2]; Chen, Lijuan[1]
	2016
卷号	79期号:21-22页码:1479-1490
URL标识	查看原文
WOS记录号	WOS:000387326700006
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4341170
专题	成都中医药大学
作者单位	1.[1]Sichuan Univ, State Key Lab Biotherapy, Collaborat Innovat Ctr Biotherapy, West China Hosp, Keyuan Rd 4,Gaopeng St, Chengdu 610041, Peoples R China 2.[2]Chengdu Univ TCM, Sch Pharm, Key Lab Standardizat Chinese Herbal Med, Minist Educ, Chengdu 611137, Peoples R China 3.[3]Sichuan Univ, Kidney Res Inst, West China Med Sch, Div Nephrol,West China Hosp, Chengdu 610041, Sichuan, Peoples R China
推荐引用方式 GB/T 7714	Li, Xiaobin[1,2],Tang, Minghai[1],Wang, Hairong[1,2],et al. In Vitro and In Vivo Primary Metabolic Characterization of F18, a Novel Histone Deacetylase-6 (HDAC6) Inhibitor, Using UHPLC-QqQ-MS/MS and Q-TOF-MS Methods[J],2016,79(21-22):1479-1490.
APA	Li, Xiaobin[1,2].,Tang, Minghai[1].,Wang, Hairong[1,2].,Ma, Liang[3].,Ye, Haoyu[1].,...&Chen, Lijuan[1].(2016).In Vitro and In Vivo Primary Metabolic Characterization of F18, a Novel Histone Deacetylase-6 (HDAC6) Inhibitor, Using UHPLC-QqQ-MS/MS and Q-TOF-MS Methods.,79(21-22),1479-1490.
MLA	Li, Xiaobin[1,2],et al."In Vitro and In Vivo Primary Metabolic Characterization of F18, a Novel Histone Deacetylase-6 (HDAC6) Inhibitor, Using UHPLC-QqQ-MS/MS and Q-TOF-MS Methods".79.21-22(2016):1479-1490.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。